(PharmaNewsWire.Com, May 04, 2017 ) According to Publisher, the Global Antiviral market is accounted for $42.65 billion in 2016 and is expected to reach $63.11 billion by 2022 growing at a CAGR of 5.8%. Increased count of people across the globe affecting from influenza, respiratory syncytial virus and epidemic of viral infections had given market a prudential base for the growth. Strong R&D and newer & advance formulations in the antiviral drugs market are expected to drive the market. However, high risk of failure and huge cost of R&D are hampering the market.
HIV antivirals segment among applications is expected to dominate the market due to increase in prevalence of HIV infections, and due to growing awareness among people. Moreover, generic drugs segment is expected to witness lucrative growth over the forecast period on account of favorable government regulations. North American market is expected to dominate the global market. However, Asia Pacific is estimated to be the fastest growing region due to growing economies and increased healthcare expenditure in the region.
Some of the key players of the Antiviral Drugs market include Abbott Laboratories, AbbVie, Inc., Aurobindo Pharma, Bristol-Myers-Squibb, Cipla, Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche AG, Gilead Sciences, GlaxoSmithKline plc., Johnson and Johnson, MedImmune/AstraZeneca, Merck & Co., Mylan N.V., Roche Diagnostics, Schering-Plough and Teva Pharmaceutical Industries Ltd.
Regions Covered: -North America -US -Canada -Mexico -Europe -Germany -France -Italy -UK -Spain -Rest of Europe -Asia Pacific -Japan -China -India -Australia -New Zealand -Rest of Asia Pacific -Rest of the World -Middle East -Brazil -Argentina -South Africa -Egypt
Company Profiling 12.1 Abbott Laboratories 12.2 AbbVie, Inc. 12.3 Aurobindo Pharma 12.4 Bristol-Myers-Squibb 12.5 Cipla 12.6 Dr. Reddy's Laboratories Ltd 12.7 F. Hoffmann-La Roche AG 12.8 Gilead Sciences 12.9 GlaxoSmithKline plc. 12.10 Johnson and Johnson 12.11 MedImmune/AstraZeneca 12.12 Merck & Co 12.13 Mylan N.V. 12.14 Roche Diagnostics 12.15 Schering-Plough 12.16 Teva Pharmaceutical Industries Ltd.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
